In vitro and in vivo studies show that the combination of resminostat (an HDAC-6 inhibitor) with docetaxel induces microtubule stabilization through the polymerization and acetylation of H3-histone into tubulin in lung cancer. The gene discussed is HDAC6; the disease is lung cancer.